The best-known leukemia symbol is the orange ribbon, worn to raise awareness of leukemia and support people living with it. In the clinic, though, hematologists read a different set of symbols: the genetic and cellular markers, such as the Philadelphia chromosome, that reveal what kind of leukemia a person has and which treatment is most likely to work. Decoding those markers is at the heart of modern diagnosis and treatment.
This article explains what leukemia is, the mechanisms behind it, how it is diagnosed, and how the markers found at diagnosis shape treatment. It draws on everyday experience in hematologic care.
What Leukemia Is
Leukemia is a group of blood cancers that start in the blood-forming tissue of the bone marrow. A developing blood cell acquires genetic changes that make it multiply uncontrollably and fail to mature properly. These abnormal white blood cells crowd out normal marrow, so the body makes too few healthy red cells, white cells and platelets.
Leukemias are classified in two ways: by speed (acute, which progresses over weeks, or chronic, which develops over months to years) and by cell lineage (lymphoid or myeloid). That gives four main types. For a wider overview, see our leukemia guide.
| Type | Cell lineage | Typical age group | Example marker |
|---|---|---|---|
| Acute lymphoblastic leukemia (ALL) | Lymphoid | Most common leukemia in children; also occurs in adults | Philadelphia chromosome in some adult cases |
| Acute myeloid leukemia (AML) | Myeloid | Mainly older adults | FLT3 or NPM1 mutations; t(15;17) in APL |
| Chronic lymphocytic leukemia (CLL) | Lymphoid | Mainly older adults | Deletion 17p or TP53 mutation (higher risk) |
| Chronic myeloid leukemia (CML) | Myeloid | Mainly adults | Philadelphia chromosome, BCR-ABL1 fusion |
Underlying Mechanisms: The Molecular Symbols
Every leukemia is driven by genetic changes in a blood stem or progenitor cell. Some of these changes are so characteristic that they act as a signature for the disease.
The Philadelphia chromosome
The classic example is the Philadelphia chromosome, created by a swap of material between chromosomes 9 and 22, written as t(9;22). It fuses two genes, BCR and ABL1, into a new gene that produces a permanently switched-on enzyme called a tyrosine kinase. This signal tells cells to keep dividing. It is found in almost all cases of CML and in a subset of ALL.
Other drivers
In AML, mutations in genes such as FLT3, NPM1 and IDH1/IDH2 affect how cells grow and mature. In acute promyelocytic leukemia, a subtype of AML, the t(15;17) translocation blocks maturation. Changes in epigenetic regulators, which control which genes are switched on, are also common. Each marker helps classify the disease and predict how it will behave.
Risk factors
Most leukemias arise without a clear cause. Recognized risk factors include previous chemotherapy or radiation therapy, high-dose radiation exposure, benzene exposure, smoking, certain inherited conditions such as Down syndrome, and some pre-existing blood disorders.
Signs and Symptoms
Symptoms mostly reflect the loss of normal blood cells:
- Fatigue, pallor and breathlessness from anemia.
- Fevers and frequent infections from a lack of working white cells.
- Easy bruising, nosebleeds or bleeding gums from low platelets.
- Bone pain, swollen lymph nodes, an enlarged liver or spleen, night sweats and unexplained weight loss.
Chronic leukemias, particularly CLL, are often found by chance on a routine blood test before any symptoms appear.
Diagnosis and Testing
Diagnosing leukemia is a step-by-step process that moves from general tests to precise molecular ones.
- Complete blood count (CBC) and blood film. These show abnormal white cell counts, anemia or low platelets, and may reveal immature cells called blasts.
- Bone marrow aspiration and biopsy. A sample of liquid marrow and a small core of bone are taken, usually from the back of the hip, to count blasts and study cell appearance. Our guide to bone marrow aspiration and biopsy explains the procedure, and our article on bone marrow aspiration indications and advances covers when it is needed.
- Flow cytometry. This identifies proteins on the cell surface to confirm the lineage and subtype.
- Cytogenetics and molecular testing. Chromosome analysis, FISH and gene sequencing detect markers such as t(9;22), FLT3 or TP53.
In general, a blast count of 20% or more in the blood or marrow is the traditional threshold for acute leukemia, although some genetic findings establish the diagnosis regardless of blast count.
Treatment: How the Markers Guide Therapy
Treatment depends on the type of leukemia, its markers, and the patient’s age and overall health.
- Chemotherapy remains the backbone of treatment for most acute leukemias, given in intensive phases.
- Targeted therapy aims directly at the driver. Tyrosine kinase inhibitors block the BCR-ABL1 protein in CML and Philadelphia-positive ALL, and have turned CML into a long-term, manageable condition for many patients. Other drugs target FLT3 or IDH mutations in AML.
- Immunotherapy, including monoclonal antibodies and CAR-T cell therapy, harnesses the immune system, especially in relapsed ALL.
- Watchful waiting is standard for early, symptom-free CLL, since treatment brings no benefit until the disease becomes active.
- Stem cell transplantation offers a chance of cure for many patients with high-risk or relapsed acute leukemia.
After treatment, the same markers are used to track measurable residual disease, the tiny amounts of leukemia that standard tests cannot see. This helps doctors decide whether more treatment is needed.
When to See a Doctor
See a doctor if you have persistent tiredness, repeated infections, unexplained bruising or bleeding, fevers or night sweats, or unexplained weight loss. These symptoms are usually due to something other than leukemia, but a simple blood count is quick and can rule it out. Seek urgent care for high fever, heavy bleeding or sudden breathlessness.
Frequently Asked Questions
What is the symbol for leukemia awareness?
The orange ribbon is the widely recognized symbol for leukemia awareness. It is worn to show support for patients and families and to encourage blood, marrow and stem cell donation.
What does the Philadelphia chromosome mean?
It is an abnormal chromosome formed when parts of chromosomes 9 and 22 swap places, creating the BCR-ABL1 fusion gene. It is the defining marker of CML and is also found in some cases of ALL. Its presence means targeted drugs called tyrosine kinase inhibitors are likely to work.
Is leukemia inherited?
Most leukemias are not inherited. The genetic changes develop in blood cells during a person’s lifetime. A small number of inherited conditions do raise the risk.
Can leukemia be cured?
Many leukemias can be cured or controlled for many years, depending on the type and the markers present. Outlooks vary widely, so your hematologist is the best source of information about your situation.
Key Takeaways
- The orange ribbon symbolizes leukemia awareness; genetic markers are the symbols doctors use to classify the disease.
- Leukemia is grouped as acute or chronic and lymphoid or myeloid.
- Diagnosis combines blood counts, marrow sampling, flow cytometry and genetic testing.
- Markers such as BCR-ABL1 guide targeted treatment and follow-up.
